You can't currently use an exchange-traded fund (ETF) to gain passive exposure to DeepSeek because it's not a publicly traded ...
When US tech stocks were crushed by the emergence of DeepSeek this week, already-cautious investors found one more reason to ...
OpenAI announced it has uncovered evidence that Chinese artificial intelligence startup DeepSeek allegedly used its ...
Domestic investors will be reacting to Q3 results from several companies, including Tata Steel, Bajaj Housing Finance, Coal ...
Tuesday's Forbes Daily covers Chinese AI DeepSeek's impact on stock market, Boeing's earnings woes, Trump's military orders, ...
The recent market sell-off over DeepSeek has put pressure on many stocks, including Robinhood. Does this dip present a smart ...
DeepSeek’s new open source AI reasoning model, R1, sparked a sell-off of Nvidia’s stock and caused its consumer app to soar ...
Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...